Abstract
The vinca alkaloids and the colchicine derivatives, although of widely disparate chemical structure, may be considered to constitute a single class of agents in view of the many similarities in their biochemical and biological actions, most notably in their ability to produce metaphase arrest. This resemblance extends to certain other unrelated compounds, including griseofulvin and podophyllotoxin.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adamson, R. H., Dixon, R. L., Ben, M., Crews, L., Shohet, S. B., Rall, D. P.: some pharmacologic properties of vincristine. arch. int. pharmacodyn. 157, 299–311 (1965).
Adelmann, M. R., Borisy, G. G., Shelanski, M. L., Weisenberg, R. C., Taylor, E. W.: Cytoplasmic filaments and tubules. Fed. Proc. 27, 1186–1193 (1968).
Afzelius, B.: Electron microscopy of the sperm tail. Results obtained with a new fixative. J. biophys. biochem. Cytol. 5, 269–278 (1959).
Agustin, B. M., Creasey, W. A.: Effects of vinca alkaloids on the synthesis of RNA in mouse brain. Nature (Lond.) 215, 965–966 (1967).
Aisenberg, A. C.: Suppression of immune response by vincristine and vinblastine. Nature (Lond.) 200, 484 (1963).
Anderson, P. J., Song, S. K., Slotwiner, P.: The fine structure of spheromembranous degeneration of skeletal muscle induced by vincristine. J. Neuropathol. exp. Neurol. 20, 15–24 (1967).
Angevtne, J. B., Jr.: Nerve destruction by colchicine in mice and golden hamsters. J. exp. Zool. 186, 363–391 (1957).
Armstrong, J. G., Dyke, R. W., Fouts, P. J., Hawthorne, J. J., Jansen, C. J, Jr., Peabody, A. M.: Initial clinical experience with vinglycinate sulfate, a molecular modification of vinblastine. Cancer Res. 27, 221–227 (1967).
Back, A., Walaszek, E. J.: Studies with radioactive colchicine. I. The influence of tumors on the tissue distribution of radioactive colchicine in mice. Cancer Res. 13, 552–555 (1953).
Barasa, A., Maccotta, V., Filogamo, G., Canavese, B.: Azione della vincaleucoblastina (VLB) sui prolungamenti, centrale e periferico, dei neuroni dei gangli spinali coltivati in vitro. Boll. Soc. Ital. Biol. Sper. 40, 860–864 (1970).
Bariéty, M., Gadjos, A.: Action de 3 substances antimitotiques sur la sideremie et la cupremie du lapin. Press Med. 73, 921 (1965).
Beer, C. T.: The leukopenic action of extracts of Vinca rosea. A. R. Brit. Emp. Cancer Campaign 38, 487–488 (1955).
Beer, C. T.: Biochemical studies with vincaleukoblastine. Canad. Cancer Conf. 4, 355–361 (1961).
Beer, C. T., Wilson, M. L., Bell, J.: A preliminary investigation of the fate of tritiated vinblastine in rats. Canad. J. Physiol. Pharmacol. 42, 368–373 (1964).
Behnke, O., Forer, A.: Evidence for four classes of microtubules in individual cells. J. cell Sci. 2, 169–192 (1967).
Behnke, O., Forer, A., Emmersen, J.: Actin in sperm tails and meiotic spindles. Nature (Lond.) 234, 408–410 (1971).
Bensch, K. G., Malawista, S. E.: Microtubule crystals in mammalian cells. J. Cell Biol. 40, 95–107 (1969).
Bensch, K. G., Marantz, R., Wisniewski, H., Shelanski, M.: Induction in vitro of micro- tubular crystals by vinca alkaloids. Science 105, 495–496 (1969).
Bent, K. J., Moore, R. H.: The mode of action of griseofulvin. In: Newton, B. A., Reynolds, P. E. (Eds.): Biochemical studies of antimicrobial drugs. London: Cambridge University Press 1966.
Borisy, G. G., Taylor, E.W.: The mechanism of action of colchicine. Binding of colchicine-3H to cellular protein. J. Cell Biol. 34, 525–533 (1967 a).
Borisy, G. G., Taylor, E. W.: Colchicine binding to sea urchin eggs and the mitotic apparatus. J. Cell Biol. 34, 535–548 (1967b).
Bradley, W. G., Lassman, L. P., Pearce, G. W., Walton, J. N.: The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies. J. neurol. Sci. 10, 107–131 (1970).
Bruchovsky, N., Owen, A. A., Becker, A. J., Till, J. E.: Effects of vinblastine on the proliferative capacity of L cells and their progress through the division cycle. Cancer Res. 25, 1232–1237 (1965).
Brues, A. M.: The fate of colchicine in the body. J. clin. Invest. 21, 646–647 (1942).
Bryan, J.: Definition of three classes of binding sites in isolated microtubule crystals. Biochemistry 11, 2611–2616 (1972).
Caner, J. E. Z.: Colchicine inhibition of chemotaxis. Arthritis Rheum. 8, 757–760 (1965).
Cardinali, G., Cardinali, G., Centurelli, G.: The Catharanthus roseus (Vinca rosea) alkaloids: a new class of stathmokinetic agents. Acta Genet, med. Gemellolog. (Roma) 17, 197–208 (1968).
Cardinali, G., Cardinali, G., Handler, A. H., Agrifoglio, M. F.: Comparative effects of colchicine and vincaleukoblastine on bone marrow mitotic activity in Syrian hamster. Proc. Soc. exp. Biol. (N.Y.) 107, 891–892 (1961).
Chung, L., Gabourel, J. D.: Adrenal steroid release by vinblastine and its contribution to vinblastine effect on rat thymus. Fed. Proc. 27, 760 (1968).
Cline, M. J.: Effect of vincristine on synthesis of ribonucleic acid and protein in leukaemic leucocytes. Brit. J. Haematol. 14, 21–29 (1968).
Cohlan, S. Q., Kitay, D.: The teratogenic effect of vincaleukoblastine in the pregnant rat. J. Pediat. 66, 541–544 (1965).
Creasey, W. A.: Tumor-inhibitory effects of combinations of the vinca alkaloids with actinomycin D. Biochem. Pharmacol. 15, 367–375 (1966).
Creasey, W. A.: The binding of antimitotic agents by cell-free extracts of tumor cells. Pharmacologist 9, 192 (1967).
Creasey, W. A.: Modifications in biochemical pathways produced by the vinca alkaloids. Cancer Chemother. Rep. 52, 501–507 (1968a).
Creasey, W. A.: Effect of the vinca alkaloids on ENA synthesis in relation to mitotic arrest. Fed. Proc. 27, 760 (1968b).
Creasey, W. A.: Biochemical effects of the vinca alkaloids — IV. Studies with vinleurosine. Biochem. Pharmacol. 18, 227–232 (1969).
Creasey, W. A.: Biochemistry of dimeric Catharanthus alkaloids. In: Taylor, W. I., Farn- Sworth, N. R. (Eds.): The Catharanthus Species: botany, chemistry and biological activity. New York: Marcel Dekker, in press.
Creasey, W. A., Bensch, K. G., Malawista, S. E.: Binding of antimitotic agents as the basis for mitotic inhibition and anti-inflammatory action. Fed. Proc. 28, 362 (1969).
Creasey, W. A., Bensch, K. G., Malawista, S. E.: Colchicine, vinblastine and griseofulvin. Pharmacological studies with human leukocytes. Biochem. Pharmacol. 20, 1579–1588 (1971).
Creasey, W. A., Choit, T. C.: The binding of colchicine by Sarcoma 180 cells. Biochem. Pharmacol. 17, 477–480 (1968).
Creasey, W. A., Markiw, M. E.: Biochemical effects of the vinca alkaloids — I. Effects of vinblastine on nucleic acid synthesis in mouse tumor cells. Biochem. Pharmacol. 13, 135–142 (1964a).
Creasey, W. A., Markiw, M. E.: Biochemical effects of the vinca alkaloids — II. A comparison of the effects of colchicine, vinblastine and vincristine on the synthesis of ribonucleic acids in Ehrlich ascites carcinoma cells. Biochim. biophys. Acta (Amst.) 87, 601–609 (1964b).
Creasey, W. A., Markiw, M. E.: Biochemical effects of the vinca alkaloids — III. The synthesis of ribonucleic acid and the incorporation of amino acids in Ehrlich ascites cells in vitro. Biochim. biophys. Acta (Amst.) 103, 635–645 (1965).
Cutts, J. H.: Changes in mitosis in ascites tumors and normal bone marrow induced by vinca-leukoblastine in vivo. Canad. Cancer Conf. 4, 363–372 (1961).
Cutts, J. H.: Effects of other agents on the biologic responses to vincaleukoblastine. Biochem. Pharmacol. 13, 421–431 (1964).
Cutts, J. H.: Protective action of diethylstilbestrol on toxicity of vinblastine in rats. J. nat. Cancer Inst. 41, 919–922 (1968).
Dahl Strom, A.: Effect of colchicine on transport of amine storage granules in sympathetic nerves of rat. European J. Pharmacol. 5, 111–113 (1968).
Da Re, P., Mancini, V., Colombo, G., Micciarelli, A.: Antimitotic effects of some basic colchicinamides on mammalian cells in vitro. Life Sci. 5, 211–213 (1966).
De Conti, R. C., Creasey, W. A.: Clinical aspects of the dimeric Catharanthus alkaloids. In: Taylor, W. I., Farnsworth, N. R. (Eds.): The Catharanthus species: botany, chemistry and biological activity. New York: Marcel Dekker, in press.
De Harven, E.: Action de la colchicine et de certaines hormones corticosurrénaliennes sur les mitoses des follicules pileux du rat. Rev. Belge Pathol. 25, 277–285 (1956).
De Harven, E., Dustin, P., Jr.: La régulation hormonale de l’éosinophilie. II. Antagonisme entre certains poisons stathmocinétiques et la cortisone au niveau des myélocytes éosinophiles du rat. Rev. Hématol. 11, 131–139 (1956).
Desjardins, R., Grogan, D. E., Arendell, J. P., Busch, H.: Effects of antitumor agents on the synthesis of nucleolar DNA. Cancer Res. 27, 159–164 (1967).
Dixon, G. J., Dulmadge, E. A., Mulligan, L. T., Mellett, L. B.: Cell culture bioassay for vincristine sulfate in sera from mice, rats, dogs and monkeys. Cancer Res. 29, 1810–1813 (1969).
Dustin, P., Jr.: New aspects of the pharmacology of antimitotic agents. Pharmacol. Rev. 15, 449–480 (1963).
Eigsti, O. J., Dustin, P., Jr.: Colchicine, in agriculture, medicine, biology and chemistry. Ames: Iowa College Press 1955.
El-Nakeeb, M. A., Lampen, J. O.: Formation of complexes of griseofulvin and nucleic acids of fungi and its relation to griseofulvin sensitivity. Biochem. J. 92, 59P–60P (1964).
El-Nakeeb, M. A., Molellan, W. L., Jr., Lampen, J. O.: Antibiotic action of griseofulvin on dermatophytes. J. Bact. 89, 557–563 (1965).
Ertel, N., Omokoku, B., Wallace, S. L.: Colchicine concentrations in leukocytes. Arthritis Rheum. 12, 293 (1969).
Ferm, V. H.: Congenital malformations in hamster embryos after treatment with vinblastine and vincristine. Science 141, 426 (1963).
Fine, R. N., Clarke, R. R., Shore, N. A.: Hyponatremia and vincristine therapy. Syndrome possibly resulting from inappropriate antidiuretic hormone secretion. Amer. J. Dis. Child. 112, 256–259 (1966).
Freed, J. J., Bhisey, A. N., Lebowitz, M. M.: The relation of microtubules and microfilaments to the motility of cultured cells. J. Cell Biol. 39, 46A–47A (1968).
Frei, E., III, Freireich, E. J.: Progress and perspectives in the chemotherapy of acute leukemia. In: Goldin, A., Hawking, F., Schnitzer, R. J. (Eds.): Advances in Chemotherapy, Vol. 2. New York: Academic Press 1965.
Frei, E., III, Whang, J., Scoggins, R. B., Van Scott, E. J., Rall, D. P., Ben, M.: The stathmokinetic effect of vincristine. Cancer Res. 24, 1918–1925 (1964).
Gailani, S. D., Armstrong, J. G., Carbone, P. P., Tan, C., Holland, J. F.: Clinical trial of vinleurosine sulfate (NSC-90636): a new drug derived from Vinca rosea Linn. Cancer Chemother. Rep. 50, 95–103 (1966).
Gawadi, N.: Actin in the mitotic spindle. Nature (Lond.) 234, 410 (1971).
Georgatsos, J.G., Karemfyllis, T.: Action of podophyllic acid on malignant tumors — II. Effects of podophyllic acid ethyl hydrazide on the incorporation of precursors into the nucleic acids of mouse mammary tumors and liver in vivo. Biochem. Pharmacol. 17, 1489–1492 (1968).
Georgatsos, J. G., Karemfyllis, T., Symeonidis, A.: Action of podophyllic acid on malignant tumors — I. Distribution of tritiated podophyllic acid ethyl hydrazide in subcellular fractions of mouse mammary tumors. Biochem. Pharmacol. 17, 1485–1488 (1968).
George, P., Journey, L. J., Goldstein, M. N.: Effect of vincristine on the fine structure of HeLa cells during mitosis. J. nat. Cancer Inst. 35, 355–375 (1965).
Gillespie, E., Levine, R. J., Malawista, S. E.: Histamine release from rat peritoneal mast cells: inhibition by colchicine and potentiation by deuterium oxide. J. Pharmacol, exp. Therap. 164, 158–165 (1968).
Goldfinger, S. E., Howell, R. R., Seegmiller, J. E.: Suppression of metabolic accompaniment of phagocytosis by colchicine. Arthritis Rheum. 8, 1112–1122 (1965).
Gonatas, N. K., Robbins, E.: The homology of spindle tubules and neurotubules in the chick embryo retina. Protoplasma 59, 377–391 (1965).
Gottschalk, P. G., Dyck, P. J., Kjely, J. M.: Vinca alkaloid neuropathy: nerve biopsy studies in rats and in man. Neurology 18, 875–882 (1968).
Graff, G. L. A., Gueuning, C., Hildebrand, J.: Action du sulfate de vincristine sur le gas- trocnémien de rat — I. Mis en évidence de deux compartiments, metaboliquement distincts, pour le phosphate inorganique; effets sur les phosphates organiques acidosolubles et les phospholipides. C.R. Soc. Biol. (Paris) 161, 2645–2651 (1967).
Greenitxs, H. F., Mointyre, R. W., Beer, C. T.: The preparation of vinblastine-4-acetyl-Í and its distribution in the blood of rats. J. med. Chem. 11, 254–257 (1968).
Hakala, M. T.: Photochemical inactivation of Vinca rosea alkaloids catalyzed by riboflavin. Fed. Proc. 28, 856 (1969).
Harris, P.: Some structural and functional aspects of the mitotic apparatus in sea urchin embryos. J. Cell Biol. 14, 475–487 (1962).
Hebden, H. F., Hadfield, J. R., Beer, C. T.: The binding of vinblastine by platelets in the rat. Cancer Ites. 30, 1417–1424 (1970).
Hell, E., Cox, D. G.: Effects of colchicine and colcemid on synthesis of deoxyribonucleic acid in the skin of the guinea pig’s ear in vitro. Nature (Lond.) 197, 287–288 (1963).
Henderson, E. S., Samaha, R. J.: Evidence that drugs in multiple combinations have materially advanced the treatment of human malignancies. Cancer Res. 29, 2272–2280 (1969).
Hertz, R., Lipsett, M. B., Moy, R. H.: Effect of vincaleukoblastine on metastatic choriocarcinoma and related trophoblastic tumors in women. Cancer Res. 20, 1050–1053 (1960).
Hodes, M. E., Rohn, R. J., Bond, W. H., Yardley, J.: Clinical trials with leurosine methiodide, an alkaloid from Vinca rosea Linn. Cancer Chemother. Rep. 28, 53–55 (1963).
Hoffman, H.: Acceleration and retardation of the processes of axon-sprouting in partially denervated muscles. Austral. J. exp. Biol. med. Sci. 30, 541–566 (1952).
Holland, J. F.: Progress in the treatment of acute leukemia, 1966. In: Dameshek,W., Dutcher, R. M. (Eds.): Perspectives in leukemia. New York: Grune and Stratton 1968.
Hunter, J. C.: Effects of vincaleukoblastine sulfate on metabolism of thioguanine-resistant L1210 leukemia cells. Biochem. Pharmacol. 12, 283–291 (1963).
Hwang, Y. F., Hamilton, H. E., Sheets, R. F.: Vinblastine-induced thrombocytosis. Lancet 2, 1075–1076 (1969).
Ilan, J., Quastel, J. H.: Effect of colchicine on nucleic acid metabolism during metamorphosis of Tenebrio molitor L. and in some mammalian tissues. Biochem. J. 100, 448–457 (1966).
Johnson, I. S.: Historical background of vinca alkaloid research and areas of future interest. Cancer Chemother. Rep. 52, 455–461 (1968).
Johnson, I. S., Armstrong, J. G., Gorman, M., Burnett, J. P., Jr.: The vinca alkaloids: a new class of oncolytic agents. Cancer Res. 23, 1390–1427 (1963).
Johnson, I. S., Hargrove, W. W., Harris, P. N., Wright, H. F., Boder, G. B.: Preclinical studies with vinglycinate, one of a series of chemically derived analogs of vinblastine. Cancer Res. 26, 2431–2436 (1966).
Johnson, I. S., Wright, H. F., Svoboda, G. H.: Experimental basis for clinical evaluation of antitumor principles derived from Vinca Rosea Linn. J. Lab. clin. Med. 54, 830 (1959).
Jones, R. G. W., Richards, J. F., Beer, C. T.: Biochemical studies with the vinca alkaloids II. Effect of vinblastine on the biosynthesis of nucleic acids and their precursors in rat thymus cells. Cancer Res. 26, 882–887 (1966).
Journey, L. J., Burdman, J., George, P.: Ultrastructural studies on tissue culture cells treated with vincristine (NSC-67574). Cancer Chemother. Rep. 52, 509–516 (1968).
Karlsson, J. O., Sjostrand, J.: The effect of colchicine on the axonal transport of protein in the optic nerve and tract of the rabbit. Brain Res. 13, 617–619 (1969).
Katchman, B. J., Zipp, R. E., Murphy, J. P. F.: The effect of chemotherapeutic agents upon the metabolism of intact human cancer cells. An in vitro technic for cell sensitivity. Clin. Chem. 9, 511–529 (1963).
Kelly, M. G., Hartwell, J. L.: The biological effects and the chemical composition of podophyllum A review. J. nat. Cancer Inst. 14, 967–1010 (1953).
Kelly, M. G., Leiter, J., Bourke, A. R., Smith, P. K.: Fate and distribution of podophyllotoxin in animals. Cancer Res. 11, 263 (1951).
Kensler, C. J.: Chemotherapeutic activity of phthalanilide derivatives. An approach to anti- codic therapy? Cancer Res. 23, 1353–1363 (1963).
Kim, J. H., Stambuk, B. K.: Synchronization of HeLa cells by vinblastine sulfate. Exp. cell Res. 44, 631–634 (1966).
Kocsis, J. J., Walaszek, E. J., Geiling, E. M.: Disposition of biosynthetically labeled 14C podophyllotoxin in normal and tumor-bearing mice. Arch. int. Pharmacodyn. 111, 134–144 (1957).
Kotorii, K., Mori, H., Yoshida, M.: A peculiar crystalline structure in neurons of rabbits treated with vincristine. Kurume med. J. 18, 57–63 (1971).
Krakoff, I. H.: Discussion of conference on gout and purine metabolism. Arthritis Rheum. 8, 760 (1965).
Krishan, A.: Time lapse and ultrastructure studies on the reversal of mitotic arrest induced by vinblastine sulfate in Earle’s L. cells. J. nat. Cancer Inst. 41, 581 — 595 (1968).
Krishan, A.: Ribosome-granular material complexes in human leukemic lymphoblasts exposed to vinblastine sulfate. J. Ultrastructure Res. 31, 272–281 (1970).
Krishan, A., Hsu, D.: Binding of colchicine-3H to vinblastine- and vincristine-induced crystals in mammalian tissue culture cells. J. Cell Biol. 48, 407–410 (1971).
Ledbetter, M. C., Porter, K. R.: Morphology of microtubules of plant cells. Science 144, 872–874 (1964).
Lits, F.: Contribution a l’études des réactions cellulaires provoquées par la colchicine. C.R. Soc. Biol. (Paris) 115, 1421–1423 (1934).
Love, R.: Studies on the cytochemistry of nucleoproteins. I. Effect of colchicine on the ribo- nucleoproteins of the cell. Exp. Cell Res. 33, 216–231 (1964).
Ludford, R. J.: Colchicine in the experimental chemotherapy of cancer. J. Nat. Cancer Inst. 6, 89–101 (1945).
Lundberg, D.: Colchicine-induced delay of the degenerative release of sympathetic transmitter in the conscious rat. Acta physiol. scand. 80, 430–432 (1970).
Luyckx, A., Van Lancker, J. L.: Metabolic effects of vinblastine. II. The effect of vinblastine on deoxyribonucleic acid and ribonucleic acid synthesis of regenerating liver. Lab. Invest. 15, 1301–1303 (1966).
Madoc-Jones, H., Mauro, F.: Interphase action of vinblastine and vincristine: differences in their lethal action through the mitotic cycle of cultured mammalian cells. J. Cell Physiol. 72, 185–196 (1968).
Malawista, S. E.: Colchicine: a common mechanism for its anti-inflammatory and antimitotic effects. Arthritis Rheum. 11, 191–197 (1968a).
Malawista, S. E.: Vinblastine: colchicine-like effects on human blood leukocytes. Arthritis Rheum. 11, 108–109 (1968b).
Malawista, S. E., Bensch, K. G.: Human polymorphonuclear leukocytes: demonstration of microtubules and effect of colchicine. Science 156, 521 — 522 (1967).
Malawista, S. E., Sato, H.: Vinblastine produces uniaxial, birefringent crystals in starfish oocytes. J. Cell Biol. 42, 596 — 599 (1969).
Malawista, S. E., Sato, H., Bensoh, K. G.: Vinblastine and griseofulvin reversibly disrupt the living mitotic spindle. Science 160, 770–772 (1968).
Malawista, S. E., Sato, H., Creasey, W. A., Bensch, K. G.: Vinblastine produces uniaxial birefringent crystals in starfish oocytes. Fed Proc. 28, 875 (1969).
Manton, I.: Observations on the microanatomy of the spermatozoid of the bracken fern (Pteridium Aquilinum). J. biophys. biochem. Cytol. 6, 413–418 (1959).
Marantz, R., Shelanski, M.: Structure of microtubule crystals induced by vinblastine in Vitro. J. Cell Biol. 44, 234–238 (1970).
Marantz, R., Ventelia, M., Shelanski, M.: Vinblastine-induced precipitation of microtubule protein. Science 165, 498–499 (1969).
Marsland, D.: Cell division-enhancement of the anti-mitotic effects of colchicine by low temperature and high pressure in the cleaving eggs of LYTECHINUS VARIEGATUS. Exp. Cell Res. 50, 369–376 (1968).
Mascitelli-Coriandoli, E., Lanzani, P.: Effects of VINCA ROSEA Linn, alkaloids on the liver coenzyme A and pantothenic acid. Arzneimittel-Forsch. 13, 1011 — 1012 (1963).
Mathe, G., Schneider, M., Band, P., Amiel, J. L., Schwarzenberg, L., Cattan, A., Sohlum-berger, J. R.: Leurosine sulfate (NSC-90636) in treatment of Hodgkin’s disease, acute lymphoblastic leukemia, and lymphoblastic lymphosarcoma. Cancer Chemother. Rep. 49, 47–49 (1965).
McGeer, P. L., MoGeer, E. G.: Effect of amethopterin and vincaleukoblastine on urinary 4-amino-5-imidazolecarboxamide. Biochem. Pharmacol. 12, 297–298 (1963).
McLeod, J. G., Penny, R.: Vincristine neuropathy: an electrophysiological and histological study. J. Neurol. Neurosurg. Psychiat. 32, 297–304 (1969).
Moncrief, J. W., Heller, K. S.: Acylation: a proposed mechanism of action for various oncolytic agents based on model chemical systems. Cancer Res. 27, 1500–1502 (1967).
Morasoa, L., Rainisio, C., Masera, G.: Duration of cytotoxic activity of vincristine in the blood of leukemic children. European J. Cancer 5, 79–80 (1969).
Morgan, J.: Microfilaments from ameba proteins. Exp. Cell Res. 65, 7–16 (1971).
Morse, B. S., Stohlman, F., Jr.: Regulation of erythropoiesis. XVIII. The effect of vincristine and erythropoietin on bone marrow. J. clin. Invest. 45, 1241–1250 (1966).
Mueller, G. A., Gaulden, M. E., Drane, W.: The effects of varying concentrations of colchicine on the progression of grasshopper neuroblasts into metaphase. J. Cell Biol. 48, 253–265 (1971).
Neuss, N., Johnson, I. S., Armstrong, J. G., Jansen, C. J., Jr.: The vinca alkaloids. In: Goldin, A., Hawking, F., Sohnitzer, R. J. (Eds.): Advances in Chemotherapy, Vol. 1. New York: Academic Press 1964.
Newoomb, E. H., Hepler, P. K.: Microtubules and fibrils in the protoplasm of COLEUS cells undergoing secondary wall deposition. J. Cell Biol. 20, 529–533 (1964).
Noble, R. L.: Symposium on vincaleukoblastine (VLB). Canad. Cancer Conf. 4, 333–338 (1961).
Noble, R. L., Beer, C. T., MoIntyre, R. W.: Biological effects of dihydrovinblastine. Cancer 20, 885–890 (1967).
Obrecht, P., Fusenig, N. E.: Die Wirkung von Vincaleukoblastin (Velbe) auf die Glykolyse von Tumorzellen. Europ. J. Cancer, 2, 109–115 (1966).
Olmsted, J. B., Carlson, K., Klebe, R., Ruddle, F., Rosenbattm, J. L.: Isolation of microtubule protein from cultured mouse neuroblastoma cells. Proc. nat. Acad. Sci. (Wash.) 65, 129–136 (1970).
Oxford, A. E., Raistrick, H., Simonet, P.: Studies in the biochemistry of microorganisms: LX. Griseofulvin: C17H, 706C1, a metabolic product of Penicillium Griseofulvum Dierckx. Biochem. J. 38, 240–248 (1939).
Padawer, J.: Quantitative studies with mast cells. Ann. N.Y. Acad. Sci. 103, 87–138 (1963).
Padawer, J.: Induction of cellular movements in mast cells by colchicine treatment. J. Cell Biol. 29, 176–180 (1966).
Palmer, C. G., Warren, A. K., Simpson, P. J.: A comparison of the cytologic effects of leurosine methiodide and vinblastine in tissue culture. Cancer Chemother. Rep. 31, 1–2 (1963).
Pfeiffer, S. E., Tolmach, L. J.: Selecting synchronous populations of mammalian cells. Nature (Lond.) 213, 139–142 (1967).
Porter, K. R.: Cytoplasmic microtubules and their functions. In: CIBA Foundation Symposium, Principles of biomolecular organization. Boston: Little, Brown 1966.
Puszkin, E., Puszkin, S., Aledort, L. M.: Colchicine-binding protein from human platelets and its effect on muscle myosin and platelet myosin-like thrombosthenin-M. J. biol. Chem. 246, 271–276 (1971).
Rice, H. V., Laetsch, W. M.: Observations on the morphology and physiology of Marsilea sperm. Amer. J. Bot. 54, 856–866 (1967).
Richards, J. F., Jones, R. G. W., Beer, C. T.: Biochemical studies with the vinca alkaloids. I. Effect on nucleic acid formation by isolated cell suspensions. Cancer Res. 26, 876–881 (1966).
Robards, A. W., Humpherson, P. G.: Microtubules and angiosperm bordered pit formation. Planta (Berlin) 77, 233–238 (1967).
Robbins, E., Gonatas, N. K.: Histochemical and ultrastructural studies on HeLa cell cultures exposed to spindle inhibitors with special reference to the interphase cell. J. Histochem. Cytochem. 12, 704–711 (1964).
Roberts, D. W., Hall, T. C., Rosenthal, D.: Coordinated changes in thymidines-monophosphate metabolism of leukocytes following vincristine administration to patients with acute granulocytic leukemia. Cancer Res. 29, 789–794 (1969).
Robertson, J. H., McCarthy, G.M.: Periwinkle alkaloids and the platelet-count. Lancet II, 353–355 (1969).
Rosenbaum,J. L., Carlson, K.: Cilia regeneration in Tetrahymena and its inhibition by colchicine. J. Cell Biol. 40, 415–425 (1969).
Sandler, S. G., Tobin, W., Henderson, E. S.: Vincristine-induced neuropathy. A clinical study of fifty leukemic patients. Neurology 19, 367–374 (1969).
Sartorelli, A. C.: Approaches to the combination chemotherapy of transplantable neoplasms. Proc. exp. Tumor Res. 6, 228–288 (1965).
Sartorelli, A. C., Creasey, W. A.: Cancer chemotherapy. Ann. Rev. Pharmacol. 9, 51–72 (1969).
Sartorelli, A. C., Creasey, W. A.: Combination chemotherapy. In: Holland, J. F., Frei, E. III. (Eds.): Cancer Medicine. Philadelphia: Lea and Febiger 1973.
Savel, H.: The metaphase-arresting plant alkaloids and cancer chemotherapy. Progr. exp. Tumor Res. 8, 189–224 (1966).
Schochet, S. S., Lampert, P. W., Earle, K. M.: Neuronal changes induced by intrathecal vincristine sulfate. J. Neuropathol. exp. Neurol. 27, 645–658 (1968).
Sentein, P.: Action de la vincaleukoblastine sur l’oeuf en segmentation et analyse du mécanisme mitotique. C.R. Acad. Sci. (Paris) 258, 4854–4857 (1964).
Shelanski, M. L., Taylor, E. W.: Isolation of a protein subunit from microtubules. J. cell Biol. 34, 549–555 (1967).
Shelanski, M. L., Wisniewski, H.: Neurofibrillary degeneration induced by vinca alkaloids: clinical and experimental. Trans. Amer. Neurol. Ass. 98, 137–140 (1968).
Slater, L. M., Wainer, R. A., Serpick, A. A.: Vincristine neurotoxicity with hyponatremia. Cancer 28, 122–125 (1969).
Slonim, R. R., Howell, D. S., Brown, H. E., Jr.: Influence of griseofulvin upon acute gouty arthritis. Arthritis Rheum. 5, 397–404 (1962).
Slotnick, I. J., Dougherty, M., James, D. H., Jr.: Vincristine inhibition of DNA synthesis in Tetrahymena pyriformis. Cancer Res. 26, 673–675 (1966).
Smith, C. G., Grady, J. E., Kupiecki, F. P.: Blood and urine levels of antitumor agents determined with cell culture methods. Cancer Res. 25, 241–245 (1965).
Sneddon, J. M.: Effect of mitosis inhibitors on blood platelet microtubules and aggregation. J. Physiol. 214, 145–158 (1971).
Spooner, B. S., Yamada, K. M., Wessells, N. K.: Microfilaments and cell locomotion. J. Cell Biol. 49, 595–613 (1971).
Stahelin, H.: 4’-Demethyl-epipodophyllotoxin thenylidene glucoside (VM-26), a podophyllin compound with a new mechanism of action. European J. Cancer. 6, 303–311 (1970).
Stahelin, H., Cerletti, A.: Experimented Ergebnisse mit den Podophyllumcytostatica SP-1 und SP-G. Schweiz. Med. Wschr. 94, 1490–1502 (1964).
Stephens, R. E.: Reassociation of microtubule protein. J. molec. Biol. 38, 517–519 (1968).
Sugar, J.: Nucleic acid changes in tumour cells following chemotherapeutics studied under the polarization and fluorescence microscope. Acta histochem. (Jena) 16, 382–392 (1963).
Symposium on Vincristine. Pediatric Division, Southwest Cancer Chemotherapy Study Group. Cancer Chemother. Rep. 52, 453–535 (1968).
Taylor, A. C.: Microtubules in the microspikes and cortical cytoplasm of isolated cells. J. Cell Biol. 28, 155–168 (1966).
Taylor, E. W.: The mechanism of colchicine inhibition of mitosis. I. Kinetics of inhibition and the binding of 3H-colehicine. J. Cell Biol. 25, 145–160 (1965).
Tilney, L. G.: Microtubules in the heliozoan Actinosphaerium nucleophilum and their relation to axopod formation and motion. J. Cell Biol. 27, 107A (1965).
Tobin,W. E., Sandler, S. G.: Depression of muscle spindle function with vincristine. Nature (Lond.) 212, 90–91 (1966).
Tobin, W. E., Sandler, S. G.: Neurophysiologic alterations induced by vincristine (NSC-67574). Cancer Chemother. Rep. 52, 519–526 (1968).
Ueda, M., Sawai, M., Kawakami, M., Minesita, T., Takeda, H.: Pressure mechanism of vincristine sulfate. Jap. J. Pharmacol. 19, 324–325 (1969).
Uy, Q. L., Moen, T. H., Johns, R. J., Owens, A. H., Jr.: Vincristine neurotoxicity in rodents. Johns Hopkins med. J. 121, 349–360 (1967).
Vaitkeyicius, V. K., Reed, M. L.: Clinical studies with podophyllum compounds SPI-77 (NSC-72274) and SPG-827 (NSC-42076). Cancer Chemother. Rep. 50, 565–571 (1966).
Valeriote, F. A., Bruce, W. R., Meeker, B. E.: A model for the action of vinblastine in vivo. Biophys. J. 6, 145–152 (1966).
Vanlancker, J. L., Flangas, A. L., Allen, J.: Metabolic effects of vinblastine. I. The effect of vinblastine on nucleic acid synthesis in spleen and bone marrow. Lab. Invest. 15, 1291–1300 (1966).
Vasiliev, J. M., Gelfand, I. M., Guelstein, V. I.: Initiation of DNA synthesis in cell cultures by colcemid. Proc. nat. Acad. Sci. (Wash.) 68, 977–979 (1971).
Venditto, J. M., Goldin, A.: Drug synergism in antineoplastic chemotherapy. In: Goldin, A., Hawking, P., Schnitzer, R.J. (Eds.): Advances in chemotherapy, Vol. 1. New York: Academic Press 1964.
Wagner, E. K., Roizman, B.: Effect of the vinca alkaloids on RNA synthesis in human cells in vitro. Science 162, 569–570 (1968).
Warneoke, P., Seeber, S.: Angriffspunkte von Vinca-alkaloiden im Protein- und Nuclein- saurestoffwechsel. Z. Krebsforsch. 71, 361–367 (1968).
Weisenberg, R. C., Borisy,G. G., Taylor, E. W.: The colchicine-binding protein of mammalian brain and its relation to microtubules. Biochemistry 7, 4466–4478 (1968).
Weisenberg, R. C., Taylor, E. W.: The binding of guanosine nucleotide to microtubule sub- unit protein purified from porcine brain. Fed. Proc. 27, 299 (1968).
Weisenberg, R. C., Timasheff, S.: Aggregation of microtubule protein induced by vinblastine. Biophys. J. 9, 174A (1969).
White, J. G.: Effects of colchicine and vinca alkaloids on human platelets. II. Changes in the dense tubular system and formation of an unusual inclusion in incubated cells. Amer. J. Pathol. 53, 447–461 (1968).
Wiernik, P. H., McLeod, R. M.: Vinblastine effect on nucleic acids and ribonuclease of lymphoid tissue. Proc. Soc. exp. Biol. (N. Y.) 119, 118–120 (1965).
Wilson, L.: Properties of colchicine binding protein from chick embryo brain. Interaction with vinca alkaloids and podophyllotoxin. Biochemistry 9, 4999–5007 (1970).
Wilson, L., Bryan, J., Ruby, A., Mazia, D.: Precipitation of proteins by vinblastine and calcium ions. Proc. nat. Acad. Sci. (Wash.) 66, 807–814 (1970).
Wilson, L., Friedkin, M.: The biochemical events of mitosis. II. The in vivo and in vitro binding of colchicine in grasshopper embryos and its possible relation to inhibition of mitosis. Biochemistry 6, 3126–3135 (1967).
Wunderlioh, F., Peyk, D.: Antimitotic agents and macronuclear division of ciliates. III. The effect of colchicine on synchronized Tetrahymena piriformis GL. Experientia (Basel) 25, 1278–1280 (1969).
Wunderlich, F., Speth,V.: Antimitotic agents and macronuclear division of ciliates. IV. Reassembly of microtubules in macronuclei of Tetrahymena adapting to colchicine. Protoplasma (Wien) 70, 139–152 (1970).
Yesair, D. W., Kohner, F. A., Rogers, W. I., Baronowsky, P., Kensler, C. J.: Relationship of phthalanilide-lipid complexes to uptake and retention of 2-chloro-4’,4”-di(2-imidazolin- 2-yl) terephthalanilide (NSC-60339) by sensitive and resistant P388 leukemia cells. Cancer Res. 26, 202–207 (1966).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 springer-Verlag Berlin-Heidelberg
About this chapter
Cite this chapter
Creasey, W.A. (1975). Vinca Alkaloids and Colchicine. In: Sartorelli, A.C., Johns, D.G. (eds) Antineoplastic and Immunosuppressive Agents. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 38 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65806-8_38
Download citation
DOI: https://doi.org/10.1007/978-3-642-65806-8_38
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65808-2
Online ISBN: 978-3-642-65806-8
eBook Packages: Springer Book Archive